NEW YORK (GenomeWeb) – Proteome Sciences said today it has conditionally raised £2.5 million ($3.9 million) through the placement of nearly 13.9 new ordinary shares of the company's stock. 

The shares were priced at 18 pence. Proteome Sciences will apply to place the shares for trading on the London Stock Exchanges' AIM on or around July 2, the company said. 

Proteome Sciences Executive Chairman Christopher Pearce has subscribed to about 1.8 million shares in the placement, while Vulpes Investment Management Private has subscribed to nearly 2.6 million shares. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.